BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 35032860)

  • 1. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
    J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.
    Tong H; Gan C; Wei B; Wang ZD; Li XD; Qian SJ; Huan H; Zhang LH; Yang Z; Chen YL; Gu YH; Chen LX; Yang YH; Wu H; Tang CW
    J Dig Dis; 2021 Jan; 22(1):31-40. PubMed ID: 33128287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of Child-Pugh score and quantitative CT-based spleen volume could predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.
    Liu J; Zhou C; Wang Y; Yang C; Shi Q; Huang S; Chen Y; Li T; Xiong B
    Abdom Radiol (NY); 2021 Jul; 46(7):3464-3470. PubMed ID: 33660042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.
    Li K; Cheng Y; Zhao R; Jiang H; Zhang L; Tong Y; Li S
    Abdom Radiol (NY); 2024 Mar; 49(3):908-918. PubMed ID: 37957372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients.
    Yin X; Zhang F; Guo H; Peng C; Zhang W; Xiao J; Wang Y; Zou X; Zhang M; Zhuge Y
    Sci Rep; 2020 Jun; 10(1):9381. PubMed ID: 32523059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
    Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
    World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt.
    Yang Y; Liang X; Yang S; He X; Huang M; Shi W; Luo J; Duan C; Feng X; Fu S; Lu L
    Eur J Radiol; 2022 Sep; 154():110384. PubMed ID: 35667296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study.
    Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM
    Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients.
    Liao Y; Zhang L; Wang JT; Yue ZD; Fan ZH; Wu YF; Zhang Y; Dong CB; Wang XQ; Cui T; Meng MM; Bao L; Chen SB; Liu FQ; Wang L
    Sci Rep; 2023 Sep; 13(1):15244. PubMed ID: 37709823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
    Li Y; He X; Pang H
    Turk J Gastroenterol; 2019 Aug; 30(8):702-707. PubMed ID: 31418414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Acad Radiol; 2024 May; 31(5):1849-1861. PubMed ID: 38007366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.
    Chen R; Luo L; Zhang YZ; Liu Z; Liu AL; Zhang YW
    World J Gastroenterol; 2024 Apr; 30(13):1859-1870. PubMed ID: 38659484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt.
    Ballester MP; Lluch P; Tosca J; Capilla M; Gómez C; Moreno O; Jordán-Iborra C; Sunsundegui P; Argemi J; Guijarro J; Mínguez M
    Dig Liver Dis; 2021 Dec; 53(12):1596-1602. PubMed ID: 34052179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: an arterial spin labeling MR study.
    Zheng G; Zhang LJ; Wang Z; Qi RF; Shi D; Wang L; Fan X; Lu GM
    Eur J Radiol; 2012 Dec; 81(12):3851-6. PubMed ID: 22832118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.